1.
Bioorg Med Chem Lett
; 20(6): 1928-32, 2010 Mar 15.
Article
in English
| MEDLINE
| ID: mdl-20167480
ABSTRACT
New adjuvants of warfarin anticoagulant activity have been developed. These compounds, which are 1,4-methano-1,2,3,4-tetrahydroanthracene-9,10-diol derivatives, act synergistically with warfarin to potentiate its anticoagulant effect. None of the compounds tested is an effective oral anticoagulant in the absence of warfarin.